Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System
Abstract
Authors
T Lemmer A Piedade T Engel L Sales C Martinez L Marcondes D Fernandez S Rojas C Mojica C Velasquez J Bustos A Arteaga